Table 4.

Kaplan–Meier Survival analysis of patients with mutations in MDS.

Mutation variable	Mutational status	N	Median OS (Months)	p value
TET2	MT	10	31.5	0.136
	WT	142	60
DNMT3A	MT	5	NR	0.79
	WT	147	60
ASXL1	MT	11	14	0.0261
	WT	141	60
RUNX1	MT	11	24	0.075
	WT	141	72
TP53	MT	9	5	< 0.0001
	WT	143	60
SF3B1	MT	28	48	0.79
	WT	124	72
SRSF2	MT	22	52	0.121
	WT	130	48
U2AF1	MT	16	NR	0.402
	WT	136	52
JAK2/3	MT	6	10	0.039
	WT	146	60
KRAS	MT	4	12	0.019
	WT	148	60
NRAS	MT	6	13	0.012
	WT	146	60
NOTCH1	MT	5	13	0.11
	WT	147	60
NPM1	MT	4	21	0.41
	WT	148	60